Glutamate and Alzheimer's disease;Glutamato y enfermedad de Alzheimer

Revista de Neurologia

Volumn 42, Issue 7, 2006, Pages 427-432

  Gazulla Abio J ^a,b   Cavero Nagore, M ^a  

^a HOSPITAL SAN JORGE   (Spain)

^b NONE   (Spain)

Author keywords

Alzheimer's disease; Excitotoxicity; Glutamate; Glutamate receptors; Glutamate transporters

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMYLOID BETA PROTEIN[25-35]; DNA; GLUTAMATE RECEPTOR; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ALZHEIMER DISEASE; DEGENERATIVE DISEASE; EXCITOTOXICITY; NEUROPATHOLOGY; NEUROTRANSMISSION; PATHOGENESIS; REVIEW; CENTRAL NERVOUS SYSTEM; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM; GLUTAMIC ACID; HUMANS; RECEPTORS, GLUTAMATE; SYNAPTIC TRANSMISSION;

EID: 33750092726     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4207.2005223     Document Type: Review

References (30)

1. Olney JW, Wozniak DF, Farber NB. Excitotoxic neurodegeneration in Alzheimer's disease. New hypothesis and new therapeutic strategies. Arch Neurol 1997; 54: 1234-40.
2. Ottersen OP, Storm-Mathisen J. Glutamate. Handbook of chemical neuroanatomy. Vol. 18. Amsterdam: Elsevier; 2002.
3. Broman J, Hassel B, Rinvik E, Ottersen OP. Biochemistry and anatomy of transmitter glutamate. In Ottersen OP, Storm-Mathisen J, eds. Glutamate. Handbook of chemical neuroanatomy. Vol. 18. Amsterdam: Elsevier; 2002. p. 1-44.
4. Vickers JC, Huntley GW, Hof PR, Bederson J, DeFelipe J, Morrison JH. Inmunocytochemical localization of non-NMDA ionotropic excitatory amino acid receptor subunits in human neocortex. Brain Res 1995; 671: 175-80.
5. Geddes JW. Glutamate receptors and excitotoxic mechanisms in Alzheimer's disease. In Peters A, Morrison JH, eds. Neurodegenerative and age-related changes in structure and function of cerebral cortex. Cerebral cortex. Vol. 14. New York: Kluver Academic/Plenum Publishers; 1999. p. 655-79.
6. Dingledine R, McBain CJ. Glutamate and aspartate. In Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD, eds. Basic neurochemistry. Molecular, cellular and medical aspects. Philadelphia: Lippincott, Williams & Wilkins; 1999. p. 315-33.
7. Cowburn RF, Fowler CJ, O'Neill C. Neurotransmitters, signal transduction and second-messengers in Alzheimer's disease. Acta Neurol Scand 1996; 93 (Suppl 165): S25-32.
8. Ferrer I. Morfopatología de la enfermedad de Alzheimer. In Alberca R, López-Pousa S, eds. Enfermedad de Alzheimer y otras demencias. Madrid: Médica Panamericana; 2002. p. 179-97.
9. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 1984; 225: 1168-70.
10. Hof PR, Bouras C, Morrison JH. Cortical neuropathology in aging and dementing disorders. In Peters A, Morrison JH, eds. Neurodegenerative and age-related changes in structure and function of cerebral cortex. Cerebral cortex. Vol. 14. New York: Kluver Academic/Plenum Publishers; 1999. p. 175-311.
11. Sasaki H, Muramoto O, Kanazawa I, Arai H, Kosaka K, Iizuka R. Regional distribution of amino acid transmitters in postmortem brains of presenile and senile dementia of Alzheimer type. Ann Neurol 1986; 19: 263-9.
12. Hyman BT, Van Hoesen GW, Damasio AR. Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone. Ann Neurol 1987; 22: 37-40.
13. Geddes JW, Chang-Chui H, Cooper SM, Lott IT, Cotman CW. Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease. Brain Res 1986; 399: 156-61.
14. Penney JB, Maragos WF, Greenamyre JT, Debowey DL, Hollingsworth Z, Young AB. Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementias. J Neurol Neurosurg Psychiatry 1990; 53: 314-20.
15. Ulas J, Cotman CW. NMDAR1 gene expression in Alzheimer's disease. Neuroscience 1997; 79: 973-82.
16. Ikonomovic MD, Mizukami K, Davies P, Hamilton R, Sheffield R, Armstrong DM. The loss of GluR2(3) immunoreactivity precedes neurofibrillary tangle formation in the entorhinal cortex and hippocampus of Alzheimer brains. J Neuropathol Exp Neurol 1997; 56: 1018-27.
17. Dewar D, Chalmers DT, Graham DI, McCulloch J. Glutamate metabotropic and AMPA binding sites are reduced in Alzheimer's disease: an autoradiographic study of the hippocampus. Brain Res 1991; 553: 58-64.
18. Scott HL, Tannenberg AE, Dodd PR. Variant forms of neuronal glutamate transporter sites in Alzheimer's disease cerebral cortex. J Neurochem 1995; 64: 2193-202.
19. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurological disorders. N Engl J Med 1994; 330: 613-22.
20. Mecocci P, MacGarvey U, Beal MF. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994; 36: 747-51.
21. Perry TL, Wee Yong V, Bergeron C, Hansen S, Jones K. Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease. Ann Neurol 1987; 21: 331-6.
22. Albin RL, Greenamyre JT. Alternative excitotoxic hypotheses. Neurology 1992, 42: 733-8.
23. Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995; 38: 357-66.
24. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346: 476-83.
25. Hoyer S. Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease. Acta Neurol Scand 1996; 93 (Suppl 165): S18-24.
26. Molina JA, De Bustos F, Jiménez-Jiménez FJ, Benito-León J, Gasalla T, Ortí-Pareja M, et al. Respiratory chain enzyme activities in isolated mitochondria of lymphocytes from patients with Alzheimer's disease. Neurology 1997; 48: 636-8.
27. Reisberg B, Doody R, Stöffler A, Schmitt F, Ferris S, Möbius HJ, et al. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 2003; 348: 1333-41.
28. Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 1991; 563: 311-4.
29. Kowall NW, Beal MF. Glutamate, glutaminase and taurine immunoreactive neurons develop neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1991; 29: 162-7.
30. Masliah E, Alford M, De Teresa R, Mallory M, Hansen L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol 1996; 40: 759-66.